Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroko Nagata

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Hepatology International|July 21, 2016
Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapyHiroko Nagata, Mina Nakagawa, Yuki Nishimura-Sakurai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 28, 2017
ITPA gene variation and ribavirin-induced anemia in patients with genotype 2 chronic hepatitis C treated with sofosbuvir plus ribavirinMiyako Murakawa, Yasuhiro Asahina, Hiroko Nagata, et al.
Biomolecules|September 23, 2022
t<sup>6</sup>A and ms<sup>2</sup>t<sup>6</sup>A Modified Nucleosides in Serum and Urine as Strong Candidate Biomarkers of COVID-19 Infection and SeverityYu Nagayoshi, Kayo Nishiguchi, Ryosuke Yamamura, et al.
The EMBO Journal|March 28, 2026
CDKAL1 dysfunction impairs lysine codon translation in podocytes and accelerates chronic kidney diseaseHiroko Nagata, Yu Nagayoshi, Takeshi Chujo, et al.
Scientific Reports|July 9, 2016
Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virusShun Kaneko, Sei Kakinuma, Yasuhiro Asahina, et al.
Journal of Gastroenterology|November 11, 2015
Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological featuresFukiko Kawai-Kitahata, Yasuhiro Asahina, Shinji Tanaka, et al.
Journal of Environmental Radioactivity|June 21, 2024
Fundamentals of wildlife dosimetry and lessons learned from a decade of measuring external dose rates in the fieldThomas G Hinton, Donovan Anderson, Edda Bæk, et al.
Gut|March 20, 2021
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysisVictor Sapena, Marco Enea, Ferran Torres, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Hepatology International|July 21, 2016
Serial measurement of Wisteria floribunda agglutinin positive Mac-2-binding protein is useful for predicting liver fibrosis and the development of hepatocellular carcinoma in chronic hepatitis C patients treated with IFN-based and IFN-free therapyHiroko Nagata, Mina Nakagawa, Yuki Nishimura-Sakurai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 28, 2017
ITPA gene variation and ribavirin-induced anemia in patients with genotype 2 chronic hepatitis C treated with sofosbuvir plus ribavirinMiyako Murakawa, Yasuhiro Asahina, Hiroko Nagata, et al.
Biomolecules|September 23, 2022
t<sup>6</sup>A and ms<sup>2</sup>t<sup>6</sup>A Modified Nucleosides in Serum and Urine as Strong Candidate Biomarkers of COVID-19 Infection and SeverityYu Nagayoshi, Kayo Nishiguchi, Ryosuke Yamamura, et al.
The EMBO Journal|March 28, 2026
CDKAL1 dysfunction impairs lysine codon translation in podocytes and accelerates chronic kidney diseaseHiroko Nagata, Yu Nagayoshi, Takeshi Chujo, et al.
Scientific Reports|July 9, 2016
Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virusShun Kaneko, Sei Kakinuma, Yasuhiro Asahina, et al.
Journal of Gastroenterology|November 11, 2015
Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological featuresFukiko Kawai-Kitahata, Yasuhiro Asahina, Shinji Tanaka, et al.
Journal of Environmental Radioactivity|June 21, 2024
Fundamentals of wildlife dosimetry and lessons learned from a decade of measuring external dose rates in the fieldThomas G Hinton, Donovan Anderson, Edda Bæk, et al.
Gut|March 20, 2021
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysisVictor Sapena, Marco Enea, Ferran Torres, et al.
Pageof 4